It is also found that the loss of miRNAs leads to unchecked SIRT1 activity, contributing to tumor growth, metastasis, and chemotherapy resistance, indicating this is one of the key processes in HCC progression (Farcas et al., 2019). The gene discussed is SIRT1; the disease is hepatocellular carcinoma.